{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:00:01Z","timestamp":1793325601427,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"GSK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Vaccines to prevent herpes zoster have been associated with reduced dementia risk. We conducted a retrospective matched cohort study of Kaiser Permanente Southern California members aged \u226565 years who received two doses of RZV 4 weeks\u20136 months apart between 01 April 2018 and 31 December 2020, with no dementia diagnoses or dementia medications prior to or within 6 months of their second RZV dose. Cox regression with inverse probability of treatment weighting was used to estimate adjusted hazard ratios (aHRs). The study included 65,800 RZV-vaccinated individuals and 263,200 unvaccinated matches. Vaccination with two doses of RZV was associated with a 51% lower risk of dementia (aHR: 0.49 [95% confidence interval (CI): 0.46\u20130.51]); aHRs were comparable across age, and racial and ethnic groups, but the risk reduction was stronger in females compared to males. In an evaluation of potential healthy vaccinee bias, the aHR of dementia for RZV compared to Tdap was 0.73 (95% CI: 0.67\u20130.79). Vaccination with two doses of RZV is associated with a statistically significant reduction in the risk of dementia in adults aged \u226565 years. After accounting for healthy vaccinee bias, RZV vaccination remains associated with a statistically significant lower risk of dementia.<\/jats:p>","DOI":"10.1038\/s41467-026-69289-0","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T12:44:25Z","timestamp":1770641065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Recombinant zoster vaccine is associated with a reduced risk of dementia"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-3475","authenticated-orcid":false,"given":"Emily","family":"Rayens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2762-9266","authenticated-orcid":false,"given":"Lina S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8001-3992","authenticated-orcid":false,"given":"Lei","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0816-7345","authenticated-orcid":false,"given":"Bradley K.","family":"Ackerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Tubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8990-2470","authenticated-orcid":false,"given":"Yi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punam P.","family":"Modha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3408-1828","authenticated-orcid":false,"given":"Raul O.","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3223-7964","authenticated-orcid":false,"given":"Elizabeth","family":"Chmielewski-Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driss","family":"Oraichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifeng","family":"Yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Koro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6184-6534","authenticated-orcid":false,"given":"Hung Fu","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"69289_CR1","unstructured":"World Health Organization. Dementia (WHO, 2025)."},{"key":"69289_CR2","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 20, 3708\u20133821 (2024).","DOI":"10.1002\/alz.13809"},{"key":"69289_CR3","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105\u2013e125 (2022)."},{"key":"69289_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10072-023-07038-7","volume":"45","author":"J Gao","year":"2024","unstructured":"Gao, J. et al. The association between varicella zoster virus and dementia: a systematic review and meta-analysis of observational studies. Neurol. Sci. 45, 27\u201336 (2024).","journal-title":"Neurol. Sci."},{"key":"69289_CR5","doi-asserted-by":"publisher","first-page":"5476","DOI":"10.1038\/s41380-021-01138-6","volume":"26","author":"M Wainberg","year":"2021","unstructured":"Wainberg, M. et al. The viral hypothesis: how herpesviruses may contribute to Alzheimer\u2019s disease. Mol. Psychiatry 26, 5476\u20135480 (2021).","journal-title":"Mol. Psychiatry"},{"key":"69289_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0863-1","volume":"18","author":"DP Devanand","year":"2018","unstructured":"Devanand, D. P. Viral hypothesis and antiviral treatment in Alzheimer\u2019s disease. Curr. Neurol. Neurosci. Rep. 18, 55 (2018).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"69289_CR7","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.jalz.2018.06.3040","volume":"14","author":"RD Moir","year":"2018","unstructured":"Moir, R. D., Lathe, R. & Tanzi, R. E. The antimicrobial protection hypothesis of Alzheimer\u2019s disease. Alzheimers Dement 14, 1602\u20131614 (2018).","journal-title":"Alzheimers Dement"},{"key":"69289_CR8","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3233\/JAD-160152","volume":"51","author":"RF Itzhaki","year":"2016","unstructured":"Itzhaki, R. F. et al. Microbes and Alzheimer\u2019s disease. J. Alzheimers Dis. 51, 979\u2013984 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"69289_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115109","volume":"44","author":"VR Hyde","year":"2025","unstructured":"Hyde, V. R. et al. Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer\u2019s disease. Cell Rep. 44, 115109 (2025).","journal-title":"Cell Rep."},{"key":"69289_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.16","volume":"1","author":"AA Gershon","year":"2015","unstructured":"Gershon, A. A. et al. Varicella zoster virus infection. Nat. Rev. Dis. Prim. 1, 15016 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"69289_CR11","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1474-4422(07)70267-3","volume":"6","author":"I Steiner","year":"2007","unstructured":"Steiner, I., Kennedy, P. G. & Pachner, A. R. The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurol. 6, 1015\u20131028 (2007).","journal-title":"Lancet Neurol."},{"key":"69289_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.1941","volume":"7","author":"S Thapa","year":"2024","unstructured":"Thapa, S. et al. Risk of dementia following herpes zoster infection among patients undertreatment versus those not: a systematic review and meta-analysis. Health Sci. Rep. 7, e1941 (2024).","journal-title":"Health Sci. Rep."},{"key":"69289_CR13","doi-asserted-by":"crossref","unstructured":"Chen, V. C. et al. Herpes zoster and dementia: a nationwide population-based cohort study. J. Clin. Psychiatry 79, 16m11312 (2018).","DOI":"10.4088\/JCP.16m11312"},{"key":"69289_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00406-020-01157-4","volume":"271","author":"S Bae","year":"2021","unstructured":"Bae, S. et al. Association of herpes zoster with dementia and effect of antiviral therapy on dementia: a population-based cohort study. Eur. Arch. Psychiatry Clin. Neurosci. 271, 987\u2013997 (2021).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"69289_CR15","doi-asserted-by":"publisher","first-page":"1471736","DOI":"10.3389\/fneur.2024.1471736","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y., Liu, W. & Xu, Y. Association between herpes zoster and Parkinson\u2019s disease and dementia: a systematic review and meta-analysis. Front. Neurol. 15, 1471736 (2024).","journal-title":"Front. Neurol."},{"key":"69289_CR16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.neuron.2022.12.029","volume":"111","author":"KS Levine","year":"2023","unstructured":"Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086\u20131093.e1082 (2023).","journal-title":"Neuron"},{"key":"69289_CR17","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3233\/JAD-220287","volume":"88","author":"DM Cairns","year":"2022","unstructured":"Cairns, D. M., Itzhaki, R. F. & Kaplan, D. L. Potential involvement of varicella zoster virus in Alzheimer\u2019s disease via reactivation of quiescent herpes simplex virus type 1. J. Alzheimers Dis. 88, 1189\u20131200 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"69289_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/ibra.12090","volume":"9","author":"MM Anwar","year":"2023","unstructured":"Anwar, M. M. The emerging mechanism behind viral infections and extracellular vesicles hypotheses leading to neuroinflammation and Alzheimer\u2019s disease pathology. Ibrain 9, 63\u201371 (2023).","journal-title":"Ibrain"},{"key":"69289_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2147\/JIR.S86958","volume":"9","author":"MR Bronzuoli","year":"2016","unstructured":"Bronzuoli, M. R., Iacomino, A., Steardo, L. & Scuderi, C. Targeting neuroinflammation in Alzheimer\u2019s disease. J. Inflamm. Res. 9, 199\u2013208 (2016).","journal-title":"J. Inflamm. Res."},{"key":"69289_CR20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(09)70134-6","volume":"8","author":"D Gilden","year":"2009","unstructured":"Gilden, D., Cohrs, R. J., Mahalingam, R. & Nagel, M. A. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 8, 731\u2013740 (2009).","journal-title":"Lancet Neurol."},{"key":"69289_CR21","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.21873\/invivo.12622","volume":"35","author":"S Lehrer","year":"2021","unstructured":"Lehrer, S. & Rheinstein, P. H. Herpes zoster vaccination reduces risk of dementia. Vivo 35, 3271\u20133275 (2021).","journal-title":"Vivo"},{"key":"69289_CR22","doi-asserted-by":"publisher","first-page":"e045871","DOI":"10.1136\/bmjopen-2020-045871","volume":"11","author":"A Lophatananon","year":"2021","unstructured":"Lophatananon, A. et al. Shingles, Zostavax vaccination and risk of developing dementia: a nested case-control study-results from the UK Biobank cohort. BMJ Open 11, e045871 (2021).","journal-title":"BMJ Open"},{"key":"69289_CR23","doi-asserted-by":"publisher","first-page":"e0257405","DOI":"10.1371\/journal.pone.0257405","volume":"16","author":"JF Scherrer","year":"2021","unstructured":"Scherrer, J. F. et al. Impact of herpes zoster vaccination on incident dementia: a retrospective study in two patient cohorts. PLoS ONE 16, e0257405 (2021).","journal-title":"PLoS ONE"},{"key":"69289_CR24","volume":"8","author":"C Schnier","year":"2022","unstructured":"Schnier, C., Janbek, J., Lathe, R. & Haas, J. Reduced dementia incidence after varicella zoster vaccination in Wales 2013-2020. Alzheimers Dement 8, e12293 (2022).","journal-title":"Alzheimers Dement"},{"key":"69289_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-1154-y","volume":"15","author":"C Remschmidt","year":"2015","unstructured":"Remschmidt, C., Wichmann, O. & Harder, T. Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review. BMC Infect. Dis. 15, 429 (2015).","journal-title":"BMC Infect. Dis."},{"key":"69289_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-9-157","volume":"9","author":"DV Ford","year":"2009","unstructured":"Ford, D. V. et al. The SAIL Databank: building a national architecture for e-health research and evaluation. BMC Health Serv. Res. 9, 157 (2009).","journal-title":"BMC Health Serv. Res."},{"key":"69289_CR27","doi-asserted-by":"crossref","unstructured":"Eyting, M. et al. A natural experiment on the effect of herpes zoster vaccination on dementia. Nature 641, 438\u2013446 (2025).","DOI":"10.1038\/s41586-025-08800-x"},{"key":"69289_CR28","unstructured":"The Medical Letter. Herpes zoster vaccine (Zostavax). Med. Lett. Drugs Ther. 48, 73\u201374 (2006)."},{"key":"69289_CR29","unstructured":"Centers for Disease Control and Prevention. What Everyone Should Know about Zostavax (Centers for Disease Control and Prevention, 2020)."},{"key":"69289_CR30","unstructured":"U.S. Food and Drug Administration. Approval letter - SHINGRIX. Vol. 2025. https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/shingrix (2017)."},{"key":"69289_CR31","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","volume":"372","author":"H Lal","year":"2015","unstructured":"Lal, H. et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N. Engl. J. Med. 372, 2087\u20132096 (2015).","journal-title":"N. Engl. J. Med."},{"key":"69289_CR32","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","volume":"375","author":"AL Cunningham","year":"2016","unstructured":"Cunningham, A. L. et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older. N. Engl. J. Med. 375, 1019\u20131032 (2016).","journal-title":"N. Engl. J. Med."},{"key":"69289_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","volume":"67","author":"KL Dooling","year":"2018","unstructured":"Dooling, K. L. et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines. MMWR Morb. Mortal. Wkly Rep. 67, 103\u2013108 (2018).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"69289_CR34","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1038\/s41591-024-03201-5","volume":"30","author":"M Taquet","year":"2024","unstructured":"Taquet, M., Dercon, Q., Todd, J. A. & Harrison, P. J. The recombinant shingles vaccine is associated with lower risk of dementia. Nat. Med. 30, 2777\u20132781 (2024).","journal-title":"Nat. Med."},{"key":"69289_CR35","doi-asserted-by":"publisher","first-page":"126673","DOI":"10.1016\/j.vaccine.2024.126673","volume":"46","author":"E Tang","year":"2025","unstructured":"Tang, E., Ray, I., Arnold, B. F. & Acharya, N. R. Recombinant zoster vaccine and the risk of dementia. Vaccine 46, 126673 (2025).","journal-title":"Vaccine"},{"key":"69289_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14283\/jpad.2023.131","volume":"11","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Jun, H., Becker, A., Wallick, C. & Mattke, S. Detection rates of mild cognitive impairment in primary care for the United States Medicare population. J. Prev. Alzheimers Dis. 11, 7\u201312 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"69289_CR37","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13195-023-01272-z","volume":"15","author":"S Mattke","year":"2023","unstructured":"Mattke, S. et al. Expected and diagnosed rates of mild cognitive impairment and dementia in the U.S. Medicare population: observational analysis. Alzheimers Res Ther. 15, 128 (2023).","journal-title":"Alzheimers Res Ther."},{"key":"69289_CR38","unstructured":"Kaiser Permanente Southern California Department of Research & Evaluation. Fast Facts. https:\/\/www.kp-scalresearch.org\/aboutus\/fast-facts\/ (2024)."},{"key":"69289_CR39","doi-asserted-by":"crossref","first-page":"ooad039","DOI":"10.1093\/jamiaopen\/ooac101","volume":"6","author":"W Chen","year":"2023","unstructured":"Chen, W. et al. Research data warehouse: using electronic health records to conduct population-based observational studies. JAMIA Open 6, ooad039 (2023).","journal-title":"JAMIA Open"},{"key":"69289_CR40","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/12-031","volume":"16","author":"C Koebnick","year":"2012","unstructured":"Koebnick, C. et al. Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm. J. 16, 37\u201341 (2012).","journal-title":"Perm. J."},{"key":"69289_CR41","unstructured":"International Society for Pharmacoepidemiology. Guidelines for Good Pharmacoepidemiology Practices (GPP) (Revision 3). https:\/\/www.pharmacoepi.org\/resources\/policies\/guidelines-08027\/Vol. 2025 (2015)."},{"key":"69289_CR42","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar. Behav. Res. 46, 399\u2013424 (2011).","journal-title":"Multivar. Behav. Res."},{"key":"69289_CR43","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/M15-1667","volume":"164","author":"SY Tartof","year":"2016","unstructured":"Tartof, S. Y. et al. Safety of seasonal influenza vaccination in hospitalized surgical patients: a cohort study. Ann. Intern Med. 164, 593\u2013599 (2016).","journal-title":"Ann. Intern Med."},{"key":"69289_CR44","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/infdis\/jiac487","volume":"227","author":"DA Salmon","year":"2023","unstructured":"Salmon, D. A., Black, S., Didierlaurent, A. M. & Moulton, L. H. Commentary on \u201ccommon vaccines and the risk of dementia: a population-based cohort study\u201d: science can be messy but eventually leads to truths. J. Infect. Dis. 227, 1224\u20131226 (2023).","journal-title":"J. Infect. Dis."},{"key":"69289_CR45","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7326\/M16-2607","volume":"167","author":"TJ VanderWeele","year":"2017","unstructured":"VanderWeele, T. J. & Ding, P. Sensitivity analysis in observational research: introducing the E-value. Ann. Intern Med. 167, 268\u2013274 (2017).","journal-title":"Ann. Intern Med."},{"key":"69289_CR46","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan, H. et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am. J. Epidemiol. 173, 676\u2013682 (2011).","journal-title":"Am. J. Epidemiol."},{"key":"69289_CR47","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/gerona\/glx229","volume":"73","author":"DH Kim","year":"2018","unstructured":"Kim, D. H. et al. Measuring frailty in medicare data: development and validation of a claims-based frailty index. J. Gerontol. A Biol. Sci. Med. Sci. 73, 980\u2013987 (2018).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69289-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69289-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T12:33:46Z","timestamp":1772195626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-69289-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["69289"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-69289-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The copyright holder for this article was incorrectly given as 'the Authors' but should have been 'GSK and the Authors' with the license 'CC BY'. The AIP article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: E.R., L.S.S., L.Q., B.K.A., Y.L., P.P.M., and H.F.T. received research funding from AstraZeneca. E.R., L.S.S., L.Q., B.K.A., J.T., Y.L., P.P.M., and H.F.T. received research funding from Moderna. ER and BKA received research funding from F2G, Inc. L.S.S., L.Q., and B.K.A. received research funding from Dynavax. B.K.A., J.T., and R.O.C. received research funding from Pfizer. B.K.A. received research funding from Genentech. E.R., L.S.S., L.Q., B.K.A., Y.L., P.P.M., and H.F.T. received research funding from GSK (unrelated to this study). E.C-Y., D.O., H.Y., and C.K. are employed by GSK and hold financial equities in GSK. The authors declare no other financial or non-financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2056"}}